Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 300,000 diagnosed incidence cases of HAP across seven major pharmaceutical markets. There are six leading marketed drugs for the treatment of HAP, and Merck is a key player in the ... Read More
-
NLP in Healthcare and Life Sciences Market by Component (Solutions and Services), NLP Type (Statistical, Hybrid), NLP Technique (IVR, OCR), Application (Clinical Trail Matching, Drug Discovery), End Users and Region - Global Forecast to 2027
... The NLP in healthcare and life sciences market size to grow from USD 2.2 billion in 2022 to USD 7.2 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 27.1% during the forecast ... Read More
-
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032
... IMCIVREE (Setmelanotide) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
TIGLUTIK Drug Insight and Market Forecast – 2032
... for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
NA Underactive Bladder Market - Industry Trends and Forecast to 2029
... report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation North America Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, ... Read More
-
MEA Underactive Bladder Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Middle East and Africa Underactive Bladder Market, By ... Read More
-
MIJ821 Emerging Drug Insight and Market Forecast – 2032
... of the MIJ821 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Frontotemporal Dementia - Market Insight, Epidemiology And Market Forecast - 2032
... as the Frontotemporal Dementia market trends in the United States, the EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Frontotemporal Dementia market report provides current treatment practices, emerging drugs, market share ... Read More
-
PCSK9 Inhibitors - Market Insight, Epidemiology and Market Forecast – 2032
... as the PCSK9i trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The PCSK9i market report provides emerging drugs, PCSK9i market share of the individual cancer types, current and ... Read More
-
Esketamine DPI Emerging Drug Insight and Market Forecast – 2032
... A detailed picture of the Esketamine DPI for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided ... Read More
-
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2032
... epidemiology as well as the PTCL market trends in the United States, the EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. PTCL market report provides current treatment practices, emerging drugs, and market ... Read More
-
AXS-05 Emerging Drug Insight and Market Forecast – 2032
... of the AXS-05 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Alcohol Use Disorder (AUD) - Market Insight, Epidemiology And Market Forecast - 2032
... and forecasted epidemiology as well as the Alcohol Use Disorder market trends in the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Alcohol Use Disorder market report provides ... Read More
-
APAC Underactive Bladder Market - Industry Trends and Forecast to 2029
... contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Asia-Pacific Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, Urethral Assist ... Read More
-
The U.S. Autism Treatment Centers Market: DataPack
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
Europe Underactive Bladder Market - Industry Trends and Forecast to 2029
... contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Europe Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, Urethral Assist ... Read More
-
Benralizumab Emerging Drug Insight and Market Forecast − 2032
... of the benralizumab for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Cholangiocarcinoma (CCA) - Market Insight, Epidemiology And Market Forecast - 2032
... as the Cholangiocarcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cholangiocarcinoma market report provides current treatment practices, emerging drugs, cholangiocarcinoma market share of the individual ... Read More
-
ION363 Emerging Drug Insight and Market Forecast – 2032
... the ION363 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Ligelizumab Emerging Drug Insight and Market Forecast − 2032
... of the ligelizumab for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
LNP023 (Iptacopan) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the LNP023 (Iptacopan) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
SPRAVATO Drug Insight and Market Forecast – 2032
... SPRAVATO for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the Intratumoral cancer therapies trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Intratumoral cancer therapies market report provides emerging drugs, Intratumoral cancer ... Read More
-
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast – 2032
... picture of the FASENRA (Benralizumab) for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report ... Read More
-
REL-1017 Emerging Drug Insight and Market Forecast – 2032
... of the REL-1017 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
Research Assistance
